Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

7 Specialty Retail Stocks to Buy Now

By Chris Lau, InvestorPlace Contributor

As the holiday season approaches, fill up your shopping carts and your portfolios with these specialty retail plays.

Why This Just Might Be the Biggest Week for CARA Stock

By Chris Lau, InvestorPlace Contributor

Cara stock is up ahead of its presentations at Kidney Week 2019. Unless it reports bad news, Cara Therapeutics looks ready to run.

Why Amazon Stock Quickly Snapped Back After Its Quarterly Earnings

By Chris Lau, InvestorPlace Contributor

Investors should no longer count on Amazon’s AWS  business boosting AMZN stock. But the core e-commerce business could lift Amazon stock.

Why Bulls Are Still in Control With AMD Stock

By Chris Lau, InvestorPlace Contributor

AMD will have no trouble growing revenue in the mid-single digits at minimum over the next few years. That suggests AMD stock gains ahead.

Qualcomm Stock Could Break Out Above 52-Week Highs as Legal Worries Abate

By Chris Lau, InvestorPlace Contributor

With no litigation worries ahead, QCOM stock is trading alongside its strong fundamentals. Mobile and ARM are the catalysts.

Load More